A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edwin Posadas, MD
RTOG Foundation
Principal Investigator - Hiram Gay, MD
RTOG Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
108 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu de Quebec - L'Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Ciuss de L'Estrie - Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Canada
- Arizona Center for Cancer Care - Gilbert
Gilbert, Arizona, United States
- Arizona Center for Cancer Care - Peoria
Peoria, Arizona, United States
- Arizona Center for Cancer Care - Phoenix
Phoenix, Arizona, United States
- Arizona Center for Cancer Care - Scottsdale East
Scottsdale, Arizona, United States
- Arizona Center for Cancer Care - Scottsdale North
Scottsdale, Arizona, United States
- Arizona Center for Cancer Care - Surprise
Surprise, Arizona, United States
- Marin Cancer Care, Inc.
Greenbrae, California, United States
- Marin Health Medical Center
Greenbrae, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Usc Medical Center - Los Angeles County
Los Angeles, California, United States
- University of Southern California
Los Angeles, California, United States
- Roseville Radiation Oncology Center
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Valley View Hospital Cancer Center
Glenwood Springs, Colorado, United States
- University of Florida Health Science Center
Gainesville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Nancy N. & J.C. Lewis Cancer & Research Pavilion
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Kansas University Cancer Center Overland Park
Overland Park, Kansas, United States
- Kansas University Cancer Center Westwood
Westwood, Kansas, United States
- East Jefferson General Hospital
Metairie, Louisiana, United States
- Lsu Healthcare Network/metairie Multi-Specialty Clinic
Metairie, Louisiana, United States
- Coastal Cancer Treatment Center - Bath
Bath, Maine, United States
- Waldo Count General Hospital - Belfast
Belfast, Maine, United States
- Maine Health/smhc Cancer Care and Blood Disorders-Biddeford
Biddeford, Maine, United States
- Maine Health/stephens Memorial - Norway
Norway, Maine, United States
- Maine Medical Center - Bramhall S Portland
Portland, Maine, United States
- Penobscot Bay Medical Center - Rockport
Rockport, Maine, United States
- Maine Health Cc of York County - Sanford
Sanford, Maine, United States
- Maine Health/smhcancer Care and Blood Disorders - Sanford
Sanford, Maine, United States
- Maine Medical Cancer Center - Scarborough Campus
Scarborough, Maine, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2019
- Primary completion
- 7 Apr 2023
- Completion
- 15 Sept 2029
- Last update posted
- 30 Dec 2025
- Registered enrollment
- 188
- Registry id
- NCT03809000
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.